TipRanks
Go Ultimate55% OFF

Peptidream (4587) Stock Forecast & Price Target

1 Followers
See the Price Targets and Ratings of:

4587 Analyst Ratings

Moderate Buy
2Ratings
2Buy0Hold0Sell
Based on 2 analysts giving stock ratings to Peptidream in the past 3 months

4587 Stock 12 Month Forecast

JPY 2,875.00▲(151.53% Upside)
Based on 2 Wall Street analysts offering 12 month price targets for Peptidream in the last 3 months. The average price target is JPY 2,875.00 with a high forecast of JPY 3,100.00 and a low forecast of JPY 2,650.00. The average price target represents a 151.53% change from the last price of JPY 1,143.00.
Highest Price TargetJPY 3,100.00Average Price TargetJPY 2,875.00Lowest Price TargetJPY 2,650.00

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for JP:4587
Price TargetFollowArticle
SBI Securities Analyst forecast on JP:4587Unknown AnalystNot RankedSBI SecuritiesJPY 3,100buy171.22%UpsideReiterated09/09/26
Goldman Sachs Analyst forecast on JP:4587Unknown AnalystNot RankedGoldman SachsJPY 2,800→JPY 2,650buy131.85%UpsideReiterated08/13/26
CitiJPY 1,100hold-3.76%DownsideReiterated07/22/26
Nomura Analyst forecast on JP:4587Unknown AnalystNot RankedNomuraJPY 2,700buy136.22%UpsideReiterated02/17/26
SMBC Nikko Analyst forecast on JP:4587Unknown AnalystNot RankedSMBC NikkoJPY 2,700buy136.22%UpsideReiterated12/10/25
Mizuho Securities Analyst forecast on JP:4587Unknown AnalystNot RankedMizuho SecuritiesJPY 4,400buy284.95%UpsideReiterated12/09/25
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AXGNAxoGen
RZLTRezolute
PTGXProtagonist Therapeutics
VRDNViridian Therapeutics
MDWDMediwound

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Peptidream

3 Months
Akinori Ueda
Akinori UedaGoldman Sachs
Success Rate0/4 ratings generated profit
0%
Average Return
-18.43%

Copying Akinori Ueda's trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -18.43% per trade.

1 Year
Akinori Ueda
Akinori UedaGoldman Sachs
Success Rate0/4 ratings generated profit
0%
Average Return
-35.10%

Copying Akinori Ueda's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -35.10% per trade.

2 Years
Akinori Ueda
Akinori UedaGoldman Sachs
Success Rate0/4 ratings generated profit
0%
Average Return
-38.65%

Copying Akinori Ueda's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -38.65% per trade.

4587 Analyst Recommendation Trends

02468Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26
Monthly rating counts for 4587
RatingJun 26Jul 26Aug 26Sep 26Oct 26
Strong Buy12321
Buy00000
Hold11100
Sell00000
Strong Sell00000
total23421

In the current month, 4587 has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 4587 average Analyst price target in the past 3 months is 2,875.00.

4587 Financial Forecast

JPY -11JPY -9.25JPY -7.5JPY -5.75JPY -4Q4 2025Q2 2026Q3 2026
HighJPY -4.67
ConsensusJPY -7.01
LowJPY -9.34

4587 Earnings Forecast

Next quarter’s earnings estimate for 4587 is -JPY 7.01 with a range of -JPY 9.34 to -JPY 4.67. The previous quarter’s EPS was -JPY 8.89. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

JPY 4.3BJPY 4.7BJPY 5BJPY 5.3BJPY 5.7BQ4 2025Q2 2026Q3 2026
HighJPY 5.54B
ConsensusJPY 5.06B
LowJPY 4.57B

4587 Sales Forecast

Next quarter’s sales forecast for 4587 is JPY 5.06B with a range of JPY 4.57B to JPY 5.54B. The previous quarter’s sales results were JPY 4.46B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

4587 Stock Forecast FAQ

What is JP:4587’s average 12-month price target, according to analysts?
Based on analyst ratings, Peptidream’s 12-month average price target is ¥2,875.00.
What is JP:4587’s upside potential, based on the analysts’ average price target?
Peptidream has 151.53% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Peptidream a Buy, Sell or Hold?
Peptidream has a consensus rating of Moderate Buy, which is based on 2 buy ratings, 0 hold ratings and 0 sell ratings.
What is Peptidream’s share price target?
The average share price target for Peptidream is ¥2,875.00. This is based on 2 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is ¥3,100.00, and the lowest forecast is ¥2,650.00. The average share price target represents a 151.53% increase from the current price of ¥1,143.
What do analysts say about Peptidream?
Peptidream’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Street analysts.
How can I buy shares of Peptidream?
To buy shares of JP:4587, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.